Cardiology
News from the FDA/CDC
Arcalyst gets FDA nod as first therapy for recurrent pericarditis
The agent, rilonacept, is already approved to treat a group of rare inherited inflammatory diseases called cryopyrin-associated periodic syndromes...
From the Journals
Blood pressure meds tied to increased schizophrenia risk
From the Journals
Ultraprocessed foods, many marketed as healthy, raise CVD risk
Conference Coverage
Imaging alternative to AVS could boost detection of primary aldosteronism
From the Journals
Dose-related AFib risk with omega-3 fatty acids?
The VITAL-RHYTHM study, showing no significant effect of low-dose omega-3 fatty acids or vitamin D on AFib risk, has been published. A look at...
Feature
High obesity rates in Southern states magnify COVID threats
At least 29 states have green-lighted obesity for inclusion in the first phases of the COVID-19 vaccine rollout. That could overwhelm government...
Guidelines
‘Major update’ of BP guidance for kidney disease; treat to 120 mm Hg
“[Chapter one] of the guidelines is devoted to blood pressure measurement ... if [targeting] 120 [mm Hg systolic], the emphasis is on 120 measured...
From the Journals
Eating fish tied to fewer CVD events in high-risk people
A report shows a significant link between eating two fish meals a week and fewer cardiovascular disease events for those with or at high risk for...
Conference Coverage
Inpatient sodium imbalances linked to adverse COVID-19 outcomes
Hypernatremia during hospitalization was associated with increased COVID-19 mortality and to a greater need for ventilatory support.
From the Journals
Obesity: A ‘double hit’ in pregnant women with heart disease
Maternal obesity may prove to be the Achilles’ heel of sustainable national efforts to reduce maternal mortality and improve health equity,...
News from the FDA/CDC
CDC data strengthen link between obesity and severe COVID
Progressively intensive management of COVID-19 might be needed for patients with more severe obesity.